Björn Nodin

Forskningsingenjör
Fler filtreringsmöjligheter
  1. 2010
  2. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

    Ehlén, Å., Brennan, D. J., Björn Nodin, O'Connor, D. P., Jakob Eberhard, Maria Alvarado-Kristensson, Jeffrey, I. B., Jonas Manjer, Jenny Brändstedt, Uhlen, M., Ponten, F. & Karin Jirström, 2010, I : Journal of Translational Medicine. 8

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2011
  4. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer

    Hjelm, B., Brennan, D. J., Zendehrokh, N., Jakob Eberhard, Björn Nodin, Gaber, A., Ponten, F., Johannesson, H., Smaragdi, K., Frantz, C., Hober, S., Louis Banka Johnson, Sven Påhlman, Karin Jirström & Uhlen, M., 2011, I : Proteomics Clinical Applications. 5, 11-12, s. 624-635

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

    Anna H Larsson, Martin Johansson, Wangefjord, S., Gaber, A., Björn Nodin, Kucharzewska, P., Charlotte Welinder, Mattias Belting, Jakob Eberhard, Anders Johnsson, Uhlen, M. & Karin Jirström, 2011, I : British Journal of Cancer. 105, 5, s. 666-672

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.

    Ehlen, O., Björn Nodin, Rexhepaj, E., Jenny Brändstedt, Uhlen, M., Maria Alvarado-Kristensson, Pontén, F., Brennan, D. J. & Karin Jirström, 2011, I : Translational Oncology. 4, 4, s. 212-221

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2012
  8. Discovery of Dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer

    Björn Nodin, Fridberg, M., Uhlen, M. & Karin Jirström, 2012, I : Journal of Ovarian Research. 5, 6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

    Björn Nodin, Fridberg, M., Ben Dror, L., Bergman, J., Uhlen, M. & Karin Jirström, 2012, I : Diagnostic Pathology. 7

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer

    Björn Nodin, Johannesson, H., Wangefjord, S., O'Connor, D. P., Ericson Lindquist, K., Uhlen, M., Karin Jirström & Jakob Eberhard, 2012, I : Diagnostic Pathology. 7, 115

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

    Anna H Larsson, Fridberg, M., Gaber, A., Björn Nodin, Levéen, P., Göran B Jönsson, Uhlen, M., Birgisson, H. & Karin Jirström, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

    Jakob Eberhard, Gaber, A., Wangefjord, S., Björn Nodin, Uhlén, M., Ericson Lindquist, K. & Karin Jirström, 2012 feb 28, I : British Journal of Cancer. 106, 5, s. 931-938 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2013
  14. Immunohistochemical and molecular studies on ovarian cancer progression and prognosis

    Björn Nodin, 2013, Pathology, Lund University. 140 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  15. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

    Karolina Boman, Anna H Larsson, Segersten, U., Kuteeva, E., Johannesson, H., Björn Nodin, Jakob Eberhard, Uhlén, M., Malmström, P-U. & Karin Jirström, 2013, I : British Journal of Cancer. 108, 11, s. 2321-2328

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases

    Anna H Larsson, Björn Nodin, Ingvar Syk, Palmquist, I., Uhlen, M., Jakob Eberhard & Karin Jirström, 2013, I : Diagnostic Pathology. 8, 109.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study

    Wangefjord, S., Sundström, M., Zendehrokh, N., Ericson Lindquist, K., Björn Nodin, Karin Jirström & Jakob Eberhard, 2013, I : Biology of Sex Differences. 4, 17.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2014
  19. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study

    Jenny Brändstedt, Wangefjord, S., Björn Nodin, Jakob Eberhard, Sundström, M., Jonas Manjer & Karin Jirström, 2014, I : PLoS ONE. 9, 6, s. e98964 e98964.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome.

    Bengtsson, E., Nerjovaj, P., Wangefjord, S., Björn Nodin, Jakob Eberhard, Uhlén, M., Signe Borgquist & Karin Jirström, 2014, I : Diagnostic Pathology. 9, 1, 78.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis

    Richard Fristedt, Jacob Elebro, Gaber, A., Ben Dror, L., Margareta Heby, Yudina, Y., Björn Nodin, Uhlén, M., Jakob Eberhard & Karin Jirström, 2014, I : PLoS ONE. 9, 11, s. e112728 e112728.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.

    Charlotta Hedner, Gaber, A., Korkocic, D., Björn Nodin, Uhlén, M., Kuteeva, E., Johannesson, H., Karin Jirström & Jakob Eberhard, 2014, I : Virchows Archiv: an international journal of pathology. 465, 6, s. 649-659

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2015
  24. Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome.

    Hedström, E., Pederiva, C., Farnebo, J., Björn Nodin, Karin Jirström, Brennan, D. J. & Farnebo, M., 2015, I : Cell Death & Disease. 6, e1892.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. The prognostic factors and multiple biomarkers in young patients with colorectal cancer.

    Wang, M-J., Ping, J., Li, Y., Adell, G., Arbman, G., Björn Nodin, Meng, W-J., Zhang, H., Yu, Y-Y., Wang, C., Yang, L., Zhou, Z-G. & Sun, X-F., 2015, I : Scientific Reports. 5, 10645.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 2016
  27. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer

    Anna H. Larsson, Sophie Lehn, Wangefjord, S., Emelie Karnevi, Kuteeva, E., Sundström, M., Björn Nodin, Uhlén, M., Jakob Eberhard, Birgisson, H. & Karin Jirström, 2016 maj 10, I : Journal of Translational Medicine. 14, 1, 128.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.

    Micke, P., Mattsson, J. S. M., Djureinovic, D., Björn Nodin, Karin Jirström, Tran, L., Jönsson, P., Maria Planck, Botling, J. & Hans Brunnström, 2016 jun, I : Journal of Thoracic Oncology. 11, 6, s. 862-872

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer

    Jonna Berntsson, Björn Nodin, Jakob Eberhard, Micke, P. & Karin Jirström, 2016 sep 1, I : International Journal of Cancer. 139, 5, s. 1129-39 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2017
  31. Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort

    Fortner, R. T., Vitonis, A. F., Schock, H., Hüsing, A., Johnson, T., Fichorova, R. N., Fashemi, T., Yamamoto, H. S., Tjønneland, A., Hansen, L., Overvad, K., Boutron-Ruault, M-C., Kvaskoff, M., Severi, G., Boeing, H., Trichopoulou, A., Benetou, V., Vecchia, C. L., Palli, D., Sieri, S. & 27 andraTumino, R., Matullo, G., Mattiello, A., Onland-Moret, N. C., Peeters, P. H., Weiderpass, E., Gram, I. T., Jareid, M., Quirós, J. R., Duell, E. J., Sánchez, M. J., Chirlaque, M-D., Ardanaz, E., Larrañaga, N., Björn Nodin, Jenny Brändstedt, Idahl, A., Khaw, K-T., Allen, N., Gunter, M., Johansson, M., Dossus, L., Merritt, M. A., Riboli, E., Cramer, D. W., Kaaks, R. & Terry, K. L., 2017 mar 20, I : Journal of Ovarian Research. 10, 1, s. 1-14 14 s., 20.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

    Wouters, J., Vizoso, M., Martinez-Cardus, A., Carmona, F. J., Govaere, O., Laguna, T., Joseph, J., Dynoodt, P., Aura, C., Foth, M., Cloots, R., van den Hurk, K., Balint, B., Murphy, I. G., McDermott, E. W., Sheahan, K., Jirström, K., Nodin, B., Mallya-Udupi, G., Van den Oord, J. J. & 2 andraGallagher, W. M. & Esteller, M., 2017 jun 5, I : BMC Medicine. 15, 1, s. 1-16 101.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker

    Corvigno, S., Frödin, M., Wisman, G. B. A., Nijman, H. W., Van der Zee, A. GJ., Karin Jirström, Björn Nodin, Hrynchyk, I., Edler, D., Ragnhammar, P., Martin Johansson, Dahlstrand, H., Mezheyeuski, A. & Östman, A., 2017 jun 13, I : The Journal of Pathology: Clinical Research. 3, 3, s. 214-224 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups

    Emma Niméus, Elin Folkesson, Björn Nodin, Linda Hartman & Klintman, M., 2017 dec 1, I : Anticancer research. 37, 12, s. 6845-6853 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2018
  36. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases

    Halla Vidarsdottir, Tran, L., Björn Nodin, Karin Jirström, Maria Planck, Mattsson, J. S. M., Botling, J., Micke, P., Jönsson, P. & Hans Brunnström, 2018, I : American Journal of Clinical Pathology. 150, 6, s. 533-544 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification

    Emelie Karnevi, Dror, L. B., Mardinoglu, A., Jacob Elebro, Margareta Heby, Olofsson, S. E., Björn Nodin, Jakob Eberhard, Gallagher, W., Uhlén, M. & Karin Jirström, 2018, I : Oncotarget. 9, 5, s. 6188-6200 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

    Kaaks, R., Fortner, R. T., Hüsing, A., Barrdahl, M., Hopper, M., Johnson, T., Tjønneland, A., Hansen, L., Overvad, K., Fournier, A., Boutron-Ruault, M. C., Kvaskoff, M., Dossus, L., Johansson, M., Boeing, H., Trichopoulou, A., Benetou, V., La Vecchia, C., Sieri, S., Mattiello, A. & 22 andraPalli, D., Tumino, R., Matullo, G., Onland-Moret, N. C., Gram, I. T., Weiderpass, E., Sánchez, M. J., Navarro Sanchez, C., Duell, E. J., Ardanaz, E., Larranaga, N., Lundin, E., Idahl, A., Karin Jirström, Björn Nodin, Travis, R. C., Riboli, E., Merritt, M., Aune, D., Terry, K., Cramer, D. W. & Anderson, K. S., 2018, I : International Journal of Cancer. 143, 3, s. 515-526

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer

    Christina Stene, Polistena, A., Gaber, A., Björn Nodin, Ottochian, B., Adawi, D., Avenia, N., Karin Jirström & Louis Banka Johnson, 2018 jan 1, I : In Vivo. 32, 1, s. 133-138 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer

    Wendel, U., Persson, N., Risinger, C., Eva Bengtsson, Björn Nodin, Lena Danielsson, Charlotte Welinder, Fredrikson, G. N., Bo Jansson & Blixt, O., 2018 feb 1, I : PLoS ONE. 13, 2, e0191872.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort

    Fortner, R. T., Schock, H., Le Cornet, C., Hüsing, A., Vitonis, A. F., Johnson, T. S., Fichorova, R. N., Fashemi, T., Yamamoto, H. S., Tjønneland, A., Hansen, L., Overvad, K., Boutron-Ruault, M. C., Kvaskoff, M., Severi, G., Boeing, H., Trichopoulou, A., Papatesta, E. M., La Vecchia, C., Palli, D. & 28 andraSieri, S., Tumino, R., Sacerdote, C., Mattiello, A., Onland-Moret, N. C., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quirós, J. R., Duell, E. J., Sánchez, M. J., Navarro, C., Ardanaz, E., Larrañaga, N., Björn Nodin, Karin Jirström, Idahl, A., Lundin, E., Khaw, K. T., Travis, R. C., Gunter, M., Johansson, M., Dossus, L., Merritt, M. A., Riboli, E., Terry, K. L., Cramer, D. W. & Kaaks, R., 2018 apr 1, I : International Journal of Cancer. 142, 7, s. 1355-1360 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort

    Cramer, D. W., Fichorova, R. N., Terry, K. L., Yamamoto, H., Vitonis, A. F., Ardanaz, E., Aune, D., Boeing, H., Brandstedt, J., Boutron-Ruault, M. C., Chirlaque, M. D., Dorronsoro, M., Dossus, L., Duell, E. J., Gram, I. T., Gunter, M., Hansen, L., Idahl, A., Johnson, T., Khaw, K. T. & 20 andraKrogh, V., Kvaskoff, M., Mattiello, A., Matullo, G., Merritt, M. A., Bjorn Nodin, Orfanos, P., Onland-Moret, N. C., Palli, D., Peppa, E., Quiros, J. R., Sanchez-Perez, M. J., Severi, G., Tjønneland, A., Travis, R. C., Trichopoulou, A., Tumino, R., Weiderpass, E., Fortner, R. T. & Kaaks, R., 2018 jul 1, I : Cancer Epidemiology Biomarkers and Prevention. 27, 7, s. 790-804 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. 2019
  44. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases

    Halla Vidarsdottir, Tran, L., Björn Nodin, Karin Jirström, Maria Planck, Jönsson, P., Mattsson, J. S. M., Botling, J., Micke, P. & Hans Brunnström, 2019, I : Human Pathology. 84, s. 221-230 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Sebastian Lundgren, Fagerström-Vahman, H., Zhang, C., Ben-Dror, L., Mardinoglu, A., Uhlen, M., Björn Nodin & Karin Jirström, 2019 jan 14, I : Biomarker research. 7, 1, 1.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift